We're truly grateful for your visit to our team page!
We will be doing the heart walk in memory of Aria in August! ? The organization that runs the congenial heart walk is the Children’s Heart Foundation. Their mission is to “advance the diagnosis, treatment, and prevention of congenital heart defects by funding the most promising research.” Part of their medical advisory team is a doctor that is at Cincinnati’s Children’s Hospital. I am looking forward to the walk and having Henry Joe there this year! I am also looking forward to meeting others that have heart angels/heart warriors!?
Our team is walking with purpose this year—celebrating 30 incredible years of The Children's Heart Foundation funding research that saves lives! Every 15 minutes in the United States, a baby is born with a congenital heart defect, making CHDs the most common birth defect in our country. For three decades, CHF has been the driving force behind the treatments and surgical advances that have transformed survival rates and given countless children with CHD the chance to thrive.
The Congenital Heart Walk is dedicated to making this impact continue. Our mission is clear—we aim to raise funds to support The Children's Heart Foundation's quest to advance the diagnosis, treatment, and prevention of CHDs by funding groundbreaking research that improves outcomes, reduces complications, and helps Heart Warriors live longer, healthier lives.
We invite you to join our team in honoring this legacy. By supporting our team or walking with us, you're contributing to research that can save and enhance the lives of infants born with CHDs, as well as children and adults living with these conditions. Together, we're part of a 30-year story of hope—and we're writing the next chapter. Your support makes a significant impact, and for that, we want to say a heartfelt thank you.
Will you join us in making a real difference? Please consider supporting our team or walking with us. Every step we take together celebrates how far we've come and funds the miracles still ahead.